3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Conditions
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Lymphoma
4
Waldenstrom Macroglobulinemia
2
Sezary Syndrome
2
Recurrence
2
Mycosis Fungoides
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Burkitt Lymphoma
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mucositis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, T-Cell
1
Interventions
Low-Level Light Therapy
5
Radiation
4
Radiotherapy
3
Propolis
3
Morphine
3
Methotrexate
3
Leucovorin
3
Cryotherapy
3
Cisplatin
3
glucarpidase
2
Probiotics
2
Pentoxifylline
2
Mouthwashes
2
Melphalan
2
Ketamine
2
Interleukin 1 Receptor Antagonist Protein
2
Honey
2
Glutamine
2
Gabapentin
2
Fluorouracil
2
Fibroblast Growth Factor 7
2
Drug Therapy
2
Amifostine
2
peppermint oil
1
pegfilgrastim
1
pegaspargase
1
oxycodone-acetaminophen
1
nelarabine
1
maltodextrin
1
kang-lai-te
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mucositis
×
nelarabine
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed